Obesity Drugmakers Reportedly Testing Medications in Children as Young as Six

STAT News reports that manufacturers of obesity treatment drugs are conducting trials involving children as young as six. This development highlights a significant expansion of clinical research into a younger, more vulnerable population for obesity management.